Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Dementia l: Introduction

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Relaxation-Compensated Chemical Exchange Saturation Transfer MRI in the Brain at 7T: Application in Relapsing-Remitting Multiple Sclerosis.

Frontiers in neurology·2022

Same author

Data quality assurance and control in cognitive research: Lessons learned from the PREDICT-HD study.

International journal of methods in psychiatric research·2017

Same author

Intra-individual Variability in Prodromal Huntington Disease and Its Relationship to Genetic Burden.

Journal of the International Neuropsychological Society : JINS·2015

Same author

Distinguishing Alzheimer's disease and dementia with Lewy bodies using cognitive and olfactory measures.

Neuropsychology·2015

Same author

Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.

The Lancet. Neurology·2014

Same author

Normative performance on the Brief Smell Identification Test (BSIT) in a multi-ethnic bilingual cohort: a Project FRONTIER study.

The Clinical neuropsychologist·2013

Search research articles

Related Experiment Video

Updated: Apr 18, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Dementia in multiple sclerosis: why is it rarely discussed?

Holly James Westervelt¹

¹Department of Neurology, Vanderbilt University School of Medicine, Nashville TN 37240, USA holly.westervelt@vanderbilt.edu.

Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists

|January 26, 2015

Summary

Cognitive deficits are common in multiple sclerosis (MS), but severe dementia is often overlooked. This study argues for defining and discussing dementia in MS to improve patient communication and care.

Keywords:

Dementia Multiple sclerosis Professional issues

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Using Retinal Imaging to Study Dementia

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Related Experiment Videos

Last Updated: Apr 18, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Using Retinal Imaging to Study Dementia

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Area of Science:

Neurology
Neuropsychology
Cognitive Science

Background:

Cognitive deficits are a known issue in multiple sclerosis (MS).
The frequency and severity of cognitive impairment, particularly dementia, are underrepresented in scientific literature.
There's a lack of open discussion regarding dementia within the MS community.

Purpose of the Study:

To highlight the underrecognized prevalence of dementia in multiple sclerosis.
To explore reasons behind the literature's omission of severe cognitive decline in MS.
To advocate for defining dementia in MS and developing patient-friendly terminology.

Main Methods:

Literature review of MS cognitive impairment studies.
Analysis of reporting trends regarding severe cognitive deficits.
Discussion of potential societal and clinical factors influencing terminology.

Main Results:

Severe cognitive deficits, including dementia, occur in multiple sclerosis with significant frequency.
Existing literature frequently minimizes or omits discussion of dementia in MS.
Reasons for this omission are multifaceted, including potential patient stigma and diagnostic challenges.

Conclusions:

Dementia is a significant, yet under-discussed, aspect of multiple sclerosis.
There is a need to formally define and acknowledge dementia in MS.
Developing sensitive terminology is crucial for patient-centered care and communication.